CYIOS Corp Reports Record Q4 Revenue Through Noir Subsidiary; Noir Full-Year Revenue Exceeds $14.4 Million

CYIOS Corp (OTC PINK:CYIO) is pleased to announce that its wholly-owned subsidiary, Noir Medical Supplies, delivered a record-breaking $5 million in revenue during Q4 2024. This significant contribution has propelled Noir's full year revenue to over $14.4 million, a substantial increase from $4.55 million in 2023, reflecting over 200% year-over-year growth. The company's success can be attributed to its strategic acquisition of Noir Medical Supplies, which closed on August 10, 2024.

Following the acquisition, CYIOS achieved significant milestones, including $2.93 million in revenue in Q3 2024 (Aug 10-Sep 30) and over $8 million in total revenue post-acquisition through December 31. For 2025, CYIOS plans to scale Noir with expanded product offerings and geographic reach, forecasting $15+ million in revenue. The company is pursuing an uplisting strategy to OTCQB or higher, including completion of a two-year PCAOB audit to enhance financial transparency.

"2024 was a transformative year for CYIOS," stated Chairman John O'Shea. "The extraordinary success of our Noir acquisition, which closed on August 10th, has not only strengthened our financial position but also set the foundation for a successful 2025."



In 2025, CYIOS Corp remains focused on delivering continued revenue growth with a solid foundation firmly in place. Key initiatives for the year include:

1. Scaling Noir: CYIOS will expand Noir's product offerings and geographic reach to achieve $15+ million in revenue. This will involve diversifying the product range to cater to the evolving needs of the healthcare sector and entering new markets to increase the customer base.
2. Uplisting Strategy: CYIOS is pursuing an uplisting strategy to OTCQB or a higher-tier exchange. This move will enhance the company's financial transparency and provide access to a broader investor base, potentially leading to increased revenue.

"CYIOS Corp is well-positioned to build on its momentum from 2024," said O'Shea, Chairman of CYIOS Corp. "We are confident investors will take notice of our new direction, successful execution driving revenue growth and delivering sustainable value for shareholders in 2025 and beyond. By focusing on revenue growth and margin expansion as the cornerstone of our strategy, we aim to create significant long-term shareholder value. With Noir now having completed two quarters under CYIOS, we anticipate consistent performance that will garner increased attention from the investment community."



About Noir Medical Supplies
Noir Medical Supplies is a rapidly growing provider of high-quality medical supplies and equipment, offering products from personal protective equipment (PPE) to essential healthcare items for clinics, hospitals, and medical professionals. Founded in 2023, Noir's mission is to solve inventory challenges for healthcare distributors and institutions across the United States and the Caribbean by delivering high-quality products at competitive prices. Noir serves some of the nation's largest healthcare and biotech companies and continues to expand its reach to meet the evolving needs of the healthcare sector.

Additional information regarding clients served as well as distribution partners can be found on the company's website. (https://noirmedicalsupplies.com/)

CYIOS Contact Information
Investors are encouraged to follow CYIOS at:
Public and Investor Relations: admin@cyioscorporation.com

About CYIOS Corporation
CYIOS Corp (OTC PINK: CYIO) is a publicly traded company focused on strategic investments and acquisitions in high-growth sectors, including healthcare, medical technology, and emerging industries. CYIOS Corp is committed to building a portfolio that delivers long-term value to shareholders through innovation and excellence. For more information, please visit: CYIOScorporation.com.

FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements." Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified using words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" & other words of similar meaning in c